Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Understanding what to look for in rewards programs can enhance your benefits. Explore essential factors to make informed choices.
17,647 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
A small auto-enrollment default in 401(K) plans can cost the average saver hundreds of thousands over a lifetime, a n...
Starting with $1,000 doesn’t require luck or timing. This guide identifies the smartest Vanguard option for a straigh...
California Gov. Gavin Newsom warned 15 cities and counties they have 30 days to align their zoning with SB 79 or face...
Value stocks are regaining ground in May as investors rotate from growth; the VLUE, AVUV, and VBR trio are delivering...
A $222 million presale for Circle’s Arc token signals a strong institutional vote of confidence. Arc aims to underpin...
Bitcoin trades around $81k as the Senate vote on crypto market rules nears. Analysts warn the outcome could spark a r...
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
Veteran investors known for patient, low-turnover strategies are guiding portfolios as markets drift higher. This pie...
In a crowded AI market, committing to a single stock for the rest of 2026 can feel risky. This guide shows a practica...
HYPE breaks above $57 as a short squeeze pushes the token within 2% of its all-time high, with negative funding and s...